Vanda Pharmaceuticals

VNDA62

$5.04arrow_drop_down1.86%-$0.09

VNDA62

$5.04

arrow_drop_down1.86%-$0.09

Performance History

Key Stats
Open	$5.47
Prev. Close	$5.40
EPS	-0.19
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	5.38	5.51
52 Week Range	3.29	6.75

Ratios







EPS	-0.19

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Vanda Pharmaceuticals (VNDA)

Vanda Pharmaceuticals Inc (VNDA) is a pharmaceutical company that specializes in the development and commercialization of innovative therapies to address unmet medical needs. The company is focused on the development of treatments for central nervous system disorders. VNDA is headquartered in Washington, DC, and was founded in 2002.

One of the key metrics that investors use to assess the value of a company is its stock price history. Looking at the historical prices of VNDA can provide insights into how the stock has performed over time. As of the most recent trading day, the stock price of VNDA was $20.50. Over the past year, the stock has traded in a range of $13.50 to $25.00.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Mihael H. Polymeropoulos M.D.
Headquarters: Washington
Employees: 290
Exchange: NASDAQ

Keep an eye on Vanda Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Vanda Pharmaceuticals 's (VNDA) price per share?

The current price per share for Vanda Pharmaceuticals (VNDA) is $5.05. The stock has seen a price change of -$0.09 recently, indicating a -1.86% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Vanda Pharmaceuticals (VNDA)?

For Vanda Pharmaceuticals (VNDA), the 52-week high is $6.75, which is 33.69% from the current price. The 52-week low is $3.3, the current price is 53.23% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Vanda Pharmaceuticals (VNDA) a growth stock?

Vanda Pharmaceuticals (VNDA) has shown an average price growth of -4.94% over the past three years. It has received a score of 22 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Vanda Pharmaceuticals as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Vanda Pharmaceuticals (VNDA) stock price performance year to date (YTD)?

As of the latest data, Vanda Pharmaceuticals (VNDA) has a year-to-date price change of 11.7%. Over the past month, the stock has experienced a price change of 5.19%. Over the last three months, the change has been -2.34%. Over the past six months, the figure is -5.8%. Looking at a longer horizon, the five-year price change stands at -67.32%.

help

Is Vanda Pharmaceuticals (VNDA) a profitable company?

Vanda Pharmaceuticals (VNDA) has a net income of $2.51M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -23.09% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $192.64M, although specific revenue growth data is currently not available. The gross profit is $192.64M. Operating income is noted at -$13.95M. Furthermore, the EBITDA is -$30.16M.

help

What is the market capitalization of Vanda Pharmaceuticals (VNDA)?

Vanda Pharmaceuticals (VNDA) has a market capitalization of $291.54M. The average daily trading volume is 5, indicating the stock's liquidity and investor engagement.